Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Interest Coverage No Debt
SPAN's Interest Coverage is ranked higher than
95% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 71.12 vs. SPAN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
SPAN' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: No Debt
Current: No Debt
0
No Debt
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SPAN's 30-Y Financials

Financials (Next Earnings Date: 2018-02-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

SPAN Guru Trades in Q3 2016

Jim Simons 72,401 sh (+3.14%)
» More
Q4 2016

SPAN Guru Trades in Q4 2016

Jim Simons 77,600 sh (+7.18%)
» More
Q1 2017

SPAN Guru Trades in Q1 2017

Jim Simons 85,100 sh (+9.66%)
» More
Q2 2017

SPAN Guru Trades in Q2 2017

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SPAN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:TPE:4106, ASX:VTI, NAS:EDAP, NAS:NVTR, XKRX:056090, OSTO:IRRAS, LSE:BQE, XKRX:208370, OTCPK:BBLG, NAS:IRIX, OSTO:BRIG, NAS:MSON, OSTO:BACTI B, LSE:KMK, ROCO:4161, XKRX:041920, ROCO:4745, LSE:CREO, OTCPK:KVMD, XKRX:004080 » details
Headquarter Location:USA
Span-America Medical Systems Inc manufactures and distributes therapeutic support surfaces and related products using polyurethane foam and other foam products and materials for the medical, consumer and industrial markets.

Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.

Ratios

vs
industry
vs
history

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.13
SPAN's Dividend Yield % is ranked higher than
78% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 1.38 vs. SPAN: 2.13 )
Ranked among companies with meaningful Dividend Yield % only.
SPAN' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.13
Current: 2.13
0
2.13
Dividend Payout Ratio 0.35
SPAN's Dividend Payout Ratio is ranked higher than
51% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 0.36 vs. SPAN: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SPAN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.35
Current: 0.35
0
0.35
Forward Dividend Yield % 2.13
SPAN's Forward Dividend Yield % is ranked higher than
74% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SPAN: 2.13 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.13
SPAN's 5-Year Yield-on-Cost % is ranked higher than
77% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. SPAN: 2.13 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SPAN' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.13
Current: 2.13
0
2.13

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $61.77
EPS (TTM) $ 1.82
Short Percentage of Float0.36%
52-Week Range $17.05 - 31.00
Shares Outstanding (Mil)2.76

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}